Pfizer and BioNTech have signed an agreement with the European Commission to supply another 200 million doses of their coronavirus vaccine. The agreement provides an option for 100 million doses. Thus, the total number of doses of the drug ordered by the EU has reached 500 million. All of them will be delivered this year.